New Prostate Cancer Surgery Aims to Aid Men with Intermediate Stage Disease

New Prostate Cancer Surgery Aims to Aid Men with Intermediate Stage Disease
Men with prostate cancer at an intermediate stage that warrants neither the active surveillance ("wait and watch") of an early cancer nor the immediate surgical removal of the prostate (prostatectomy) of an advanced cancer may have a treatment option — high intensity focused ultrasound (HIFU), doctors at NYU Langone Medical Center report. HIFU is a type of cancer surgery pioneered by clinician-scientists at the Langone Center. Doctors deliver the treatment using a machine that gives off high frequency sound waves that deliver a strong beam to cancer cells. The directed ultrasound energy ablates cancer tissue and only a rim of nearby normal tissue, the center reported, minimizing healthy tissue loss and reducing side effects, such as urinary incontinence and erectile dysfunction. "This technology provides important treatment for a niche group of men with prostate cancer who otherwise have limited options for care," Herbert Lepor, MD, the Martin Spatz chair and professor of Urology at NYU Langone, said in a press release. "It was rewarding to see our first patient leave our out-patient facility in the afternoon, enjoy dinner with his wife that night, and report no adverse impact on erectile function three days later." Dr. Lepor and colleagues at NYU Langone were the first in the northeastern U.S. to use Sonablate, developed by SonaCare Medical, for the treatment of localized prostate cancer, the release stated. During the procedure, an ultrasound probe is inser
Subscribe or to access all post and page content.